Literature DB >> 20575034

Pain rate and social circumstances rather than cumulative organ damage determine the quality of life in adults with sickle cell disease.

Charlotte F J van Tuijn, Eduard J van Beers, John-John B Schnog, Bart J Biemond.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20575034      PMCID： PMC7159444          DOI： 10.1002/ajh.21731

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
Additional Supporting Information may be found in the online version of this article. Table 4: Patient characteristics. Table 5: QoL in relation occupation. Table 6: QoL in relation to education. Click here for additional data file.
  23 in total

1.  Pain management in sickle cell disease.

Authors:  Matthew J Booker; Kate L Blethyn; Christine J Wright; Sheila M Greenfield
Journal:  Chronic Illn       Date:  2006-03

2.  Rapid analysis of hemoglobin variants by cation-exchange HPLC.

Authors:  C N Ou; C L Rognerud
Journal:  Clin Chem       Date:  1993-05       Impact factor: 8.327

Review 3.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Authors:  Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood Rev       Date:  2006-11-07       Impact factor: 8.250

4.  Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP).

Authors:  Beatrice Files; Don Brambilla; Abdullah Kutlar; Scott Miller; Elliott Vichinsky; Winfred Wang; Suzanne Granger; Robert J Adams
Journal:  J Pediatr Hematol Oncol       Date:  2002-05       Impact factor: 1.289

5.  Sickle cell disease: Pain, coping and quality of life in a study of adults in the UK.

Authors:  Kofi A. Anie; Andrew Steptoe; David H. Bevan
Journal:  Br J Health Psychol       Date:  2002-09

6.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.

Authors:  C A McHorney; J E Ware; J F Lu; C D Sherbourne
Journal:  Med Care       Date:  1994-01       Impact factor: 2.983

7.  Daily assessment of pain in adults with sickle cell disease.

Authors:  Wally R Smith; Lynne T Penberthy; Viktor E Bovbjerg; Donna K McClish; John D Roberts; Bassam Dahman; Imoigele P Aisiku; James L Levenson; Susan D Roseff
Journal:  Ann Intern Med       Date:  2008-01-15       Impact factor: 25.391

8.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

9.  Health related quality of life in sickle cell patients: the PiSCES project.

Authors:  Donna K McClish; Lynne T Penberthy; Viktor E Bovbjerg; John D Roberts; Imoigele P Aisiku; James L Levenson; Susan D Roseff; Wally R Smith
Journal:  Health Qual Life Outcomes       Date:  2005-08-29       Impact factor: 3.186

10.  Hydroxyurea and sickle cell anemia: effect on quality of life.

Authors:  Samir K Ballas; Franca B Barton; Myron A Waclawiw; Paul Swerdlow; James R Eckman; Charles H Pegelow; Mabel Koshy; Bruce A Barton; Duane R Bonds
Journal:  Health Qual Life Outcomes       Date:  2006-08-31       Impact factor: 3.186
View more
  8 in total

Review 1.  Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review.

Authors:  Joep W R Sins; David J Mager; Shyrin C A T Davis; Bart J Biemond; Karin Fijnvandraat
Journal:  Blood Adv       Date:  2017-08-22

2.  Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial.

Authors:  Mohammed S Alshahrani; Amal H AlSulaibikh; Mohamed R ElTahan; Sukayna Z AlFaraj; Laila P Asonto; Abdullah A AlMulhim; Murad F AlAbbad; Nisreen Almaghraby; Mohammed A AlJumaan; Thamir O AlJunaid; Moath N Darweesh; Faisal M AlHawaj; Alaa M Mahmoud; Bader K Alossaimi; Shaikhah K Alotaibi; Talal M AlMutairi; Duaa A AlSulaiman PharmD; Dunya Alfaraj; Reem Alhawwas; Lawrence Mbuagbaw; Kim Lewis; Madeleine Verhovsek; Mark Crowther; Gordon Guyatt; Waleed Alhazzani
Journal:  Acad Emerg Med       Date:  2021-09-21       Impact factor: 5.221

3.  High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study.

Authors:  Ifeyinwa Osunkwo; Thomas R Ziegler; Jessica Alvarez; Courtney McCracken; Korin Cherry; Chinyere E Osunkwo; Solomon F Ofori-Acquah; Samit Ghosh; Adeolu Ogunbobode; Jim Rhodes; James R Eckman; Carlton Dampier; Vin Tangpricha
Journal:  Br J Haematol       Date:  2012-08-28       Impact factor: 6.998

4.  Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.

Authors:  Kenneth I Ataga; Abdullah Kutlar; Julie Kanter; Darla Liles; Rodolfo Cancado; João Friedrisch; Troy H Guthrie; Jennifer Knight-Madden; Ofelia A Alvarez; Victor R Gordeuk; Sandra Gualandro; Marina P Colella; Wally R Smith; Scott A Rollins; Jonathan W Stocker; Russell P Rother
Journal:  N Engl J Med       Date:  2016-12-03       Impact factor: 91.245

Review 5.  Sickle cell vaso-occlusion: The dialectic between red cells and white cells.

Authors:  Nicola Conran; Stephen H Embury
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-01

6.  The Correlation Between Surgical Procedures and Quality of Life Among Sickle Cell Disease Patients: A Perspective Saudi Study.

Authors:  Ali J Al Saad; Rayan A Buhalim; Faisal A Al Jabr; Abdulaziz M Al Dehailan; Abdulaziz A Albahrani
Journal:  Cureus       Date:  2022-01-18

7.  A randomized controlled trial studying the effectiveness of group medical appointments on self-efficacy and adherence in sickle cell disease (TEAM study): study protocol.

Authors:  Marlous J Madderom; Jessica Heijdra; Elisabeth M W J Utens; Suzanne Polinder; Anita W Rijneveld; Marjon H Cnossen
Journal:  BMC Hematol       Date:  2016-08-04

8.  Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.

Authors:  Aafke E Gaartman; Ajab K Sayedi; Jorn J Gerritsma; Tim R de Back; Charlotte F van Tuijn; Man Wai Tang; Harriët Heijboer; Koen de Heer; Bart J Biemond; Erfan Nur
Journal:  Br J Haematol       Date:  2021-07-15       Impact factor: 6.998
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.